vancomycin has been researched along with Pneumonia, Bacterial in 87 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (9.20) | 18.2507 |
| 2000's | 33 (37.93) | 29.6817 |
| 2010's | 40 (45.98) | 24.3611 |
| 2020's | 6 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Mause, E; Selim, M; Velagapudi, M | 1 |
| Li, F; Sun, L; Wang, X; Wang, Y | 1 |
| Bosheva, M; Gujabidze, R; Hamed, KA; Károly, É; Nemeth, A; Saulay, M; Smart, JI | 1 |
| Lo, CK; Sheth, PM | 1 |
| Peters, AT; Pickens, CI; Postelnick, MJ; Qi, C; Wunderink, RG; Zembower, TR | 1 |
| Capitano, B; El-Solh, AA; Liu, P; Stein, A | 1 |
| Castellazzi, ML; Claut, LE; Colombo, C; Daccò, V; Esposito, S | 1 |
| Alemkere, G; Engidawork, E; Tenna, A | 1 |
| Bukur, M; Ley, EJ; Liou, DZ; Margulies, DR; Mirocha, J; Salim, A; Singer, MB; Srour, M | 1 |
| Barriere, SL; Corey, GR; Genter, FC; Lentnek, AL; Luna, CM; Magana-Aquino, M; Niederman, MS; Rubinstein, E; Stryjewski, ME; Torres, A | 1 |
| Fukami, K; Furuta, K; Ito, K; Mizokami, F; Mizuno, T; Nagamatsu, T; Shibasaki, M | 1 |
| García-Bujalance, S; Muñoz-Vélez, M | 1 |
| Caffrey, AR; Laplante, KL; Morrill, HJ; Puzniak, LA | 1 |
| Barriere, SL | 1 |
| Dhanireddy, R; Dolapo, O; Talati, AJ | 1 |
| Buche, M; Dive, A; Floria, M; Marchandise, B; Schroder, E | 1 |
| Chen, Z; Cheng, H; Deng, QW; Pan, WG; Yang, WZ; Yu, ZJ; Zheng, JX | 1 |
| Chung, DR; Huh, K | 1 |
| Maraki, S; Papadakis, IS | 1 |
| Attridge, RT; Frei, CR; Mortensen, EM; Reveles, KR | 1 |
| Chen, Y; Gao, X; Haider, S; Li, Q; Liu, S; Wan, Y | 1 |
| Blumer, JL; Bradley, JS; Cannavino, C; Friedland, HD; Ghonghadze, T; Jandourek, A; O'Neal, T | 1 |
| Fukumori, S; Ishibashi, T; Iwamura, N; Kasai, H; Mizoguchi, A; To, H; Tsuji, Y | 1 |
| Bae, S; Choi, SH; Chong, YP; Kim, HS; Kim, MC; Kim, MN; Kim, SH; Kim, YS; Lee, SO; Park, SJ; Sung, H; Woo, JH | 1 |
| Kaysin, A; Viera, AJ | 1 |
| Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X | 1 |
| Chang, CC; Chen, CL; Hsieh, YY; Tsai, HD | 1 |
| Baba, H; Kuzuya, T; Nabeshima, T; Yamada, K; Yamamoto, M | 1 |
| Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H | 1 |
| Beibei, L; Mengli, C; Nan, B; Rui, W; Xuhong, Y; Yun, C | 1 |
| Stein, GE; Wells, EM | 1 |
| Furlanut, M; Pea, F; Viale, P | 1 |
| Hermsen, ED; Kalil, AC; Murthy, MH; Neto, FK; Rupp, ME; Sun, J | 1 |
| Gonzalez, F; Li, X; Mu, D; Tang, J; Wang, H; Xiong, Y | 1 |
| Burkhardt, O; Pletz, MW; Welte, T | 1 |
| Cauda, R; Esposito, S; Garau, J; Gould, IM; Gudiol, F; Mazzei, T | 1 |
| Hedge, DD; Hellwig, TR; Laible, BR | 1 |
| Tarchini, G | 1 |
| Lemonovich, TL; Watkins, RR | 1 |
| Avazashvili, N; Chikviladze, D; Gachechiladze, Kh; Metreveli, D; Mikeladze, M; Nozadze, T | 1 |
| Deming, P; Marr-Lyon, L; Mercier, RC; North, MS; Sakoulas, G; Walraven, CJ | 1 |
| Cano, EL; Cely, CM; Ford, KD; Haque, NZ; Kett, DH; Peyrani, P; Ramirez, JA; Scerpella, EG; Welch, VL; Zervos, MJ | 1 |
| Choi, SH; Chung, J; Hong, SB; Jang, HJ; Kim, JW; Koh, Y; Lim, CM | 1 |
| Cambon, A; Kong, M; Smith, MJ; Woods, CR | 1 |
| Escassi-Gil, Á; Garrido-Pérez, JI; Lasso-Betancor, CE | 1 |
| Clark, CR; Karau, MJ; Patel, R; Rajagopalan, G; Schmidt, SM; Tilahun, AY | 1 |
| Corey, GR; Nannini, EC; Stryjewski, ME | 1 |
| Arnold, FW; Griffin, AT; Peyrani, P; Ramirez, JA; Wiemken, TL | 1 |
| Pigrau, C | 1 |
| Cammarata, SK; Kollef, MH; Oliphant, TH; Wunderink, RG | 1 |
| Adler, S; Bruss, JB; Deville, J; Edge-Padbury, B; Jantausch, BA; Lopez, P; Morfin, MR; Naberhuis-Stehouwer, S | 1 |
| Buchheidt, D; Hofheinz, R; Hummel, M | 1 |
| Cammarata, SK; Kuter, DJ; Le, VH; Nasraway, SA; O'Grady, N; Shorr, AF | 1 |
| Cammarata, SK; Croos-Dabrera, RV; Kollef, MH; Rello, J; Wunderink, RG | 1 |
| Gallaher, KJ; Pickett, KC | 1 |
| Rollins, G | 1 |
| Kalil, AC; Puumala, SE; Stoner, J | 1 |
| Blazic, M; Fontana, F; Gregori, D; Milanese, M; Oblach, L; Piacente, N; Silvestri, L; van Saene, HK | 1 |
| Wunderink, RG | 1 |
| Hiramatsu, K; Hsu, LY; Kapi, M; Koh, TH; Sng, LH; Wang, GC | 1 |
| Alvarez-Lerma, F; del Castillo, A; Grau, S; Neipp, R; Rubio-Terrés, C | 1 |
| Wilcox, MH | 1 |
| Al-Tawfiq, JA; Aldaabil, RA | 1 |
| Akasaka, T; Mihm, MC; Onodera, H; Yoshida, A | 1 |
| Agudelo, M; Rodriguez, CA; Salazar, BE; Vesga, O; Zapata, AX; Zuluaga, AF | 1 |
| Barberá Farré, JR; Carranza González, R; Fernández Cenjor, J; Prieto Gómez, E; Tena Gómez, D | 1 |
| Koulenti, D; Rello, J | 1 |
| Kollef, MH; Micek, ST; Skrupky, LP | 1 |
| Gerónimo-Pardo, M | 1 |
| Bayston, R | 1 |
| Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
| Cuschieri, P; Galizia, AC; Vassallo, J | 1 |
| Ben, RJ; Chi, WM; Chu, ML; Lu, JJ; Wang, CC; Wang, JC; Young, TG | 1 |
| Davis, JM; Hong, J | 1 |
| Borderas, F; Delgado, J; Gallardo, JA; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
| Alfandari, S; Beaucaire, G; Dhennain, C; Georges, H; Guery, B; Leroy, O; Roussel-Delvallez, M | 1 |
| Baraia-Etxaburu, J; Cisterna, R; Malero, P; Muñoz, J; Santamaría, JM; Teira, R; Unzaga, MJ | 1 |
| Hitomi, S; Kimura, S; Mori, N; Okuzumi, K; Sugishita, C; Yoneyama, A | 1 |
| Basso, M; Costa, SF; Levin, AS; Newbaer, M; Santos, CR; Soares, I | 1 |
| Forest, G; Henry, M; Oldach, D; Simsir, A | 1 |
| Bang, RL; George, A; Gupta, R; Khalaf, EM | 1 |
| Servais, H; Tulkens, PM | 1 |
| Ebsen, M; Franke, RP; Franz, AR; Hummler, HD; Pohlandt, F; Röhlke, W | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
| Andrieu, P; Archambaud, M; Bonnet, E; Chabanon, G; Chaminade, B; Conil, JM; Cougot, P; Decun, JF; Georges, B; Houin, G; Roche, C; Saivin, S; Samii, K; Virenque, C | 1 |
18 review(s) available for vancomycin and Pneumonia, Bacterial
| Article | Year |
|---|---|
Cefazolin-induced hemolytic anemia: a case report and systematic review of literature.
Topics: Aged, 80 and over; Anemia, Hemolytic; Anti-Bacterial Agents; Cefazolin; Female; Humans; Pneumonia, Bacterial; Sepsis; Vancomycin | 2021 |
Vancomycin-resistant Enterococcus faecium pneumonia in a uremic patient on hemodialysis: a case report and review of the literature.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Renal Dialysis; Treatment Outcome; Uremia; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2020 |
Carnobacterium inhibens isolated in blood culture of an immunocompromised, metastatic cancer patient: a case report and literature review.
Topics: Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Androgen Antagonists; Anti-Bacterial Agents; Bacteremia; Blood Culture; Canada; Carnobacterium; Ceftriaxone; Food Microbiology; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Male; Pneumonia, Bacterial; Prostatic Neoplasms; Vancomycin | 2021 |
Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Early Diagnosis; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pandemics; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Vancomycin | 2015 |
Rothia mucilaginosa pneumonia: a literature review.
Topics: Anti-Bacterial Agents; beta-Lactams; Hematologic Neoplasms; Humans; Immunocompetence; Immunocompromised Host; Lung; Male; Micrococcaceae; Middle Aged; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Radiography; Vancomycin | 2015 |
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2010 |
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Education, Medical, Continuing; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Randomized Controlled Trials as Topic; Renal Insufficiency; Teicoplanin; Thrombocytopenia; Vancomycin | 2010 |
Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2010 |
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Teicoplanin; Tigecycline; Treatment Outcome; Vancomycin | 2011 |
Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies.
Topics: Aminoglycosides; Anti-Bacterial Agents; Creatinine; Cross Infection; Drug Administration Schedule; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2012 |
[Oxazolidinones and glycopeptides].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Biotransformation; Cell Wall; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Histamine Release; Humans; Linezolid; Molecular Structure; Oxazolidinones; Peptidoglycan; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Vancomycin | 2003 |
[Stakes, treatment strategies and progression of MRSA nosocomial pneumonia, especially pneumonia due to mechanical ventilation].
Topics: Acute Disease; Anti-Bacterial Agents; Critical Care; Cross Infection; Disease Progression; Drug Monitoring; Hospital Mortality; Humans; Kidney Diseases; Methicillin Resistance; Microbial Sensitivity Tests; Patient Selection; Pneumonia, Bacterial; Prognosis; Respiration, Artificial; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin | 2004 |
Update on linezolid: the first oxazolidinone antibiotic.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Teicoplanin; Vancomycin | 2005 |
Drug-induced linear IgA bullous dermatosis.
Topics: Aged; Anti-Bacterial Agents; Biopsy, Needle; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoglobulin A; Immunohistochemistry; Pneumonia, Bacterial; Prednisolone; Risk Assessment; Severity of Illness Index; Skin Diseases, Vesiculobullous; Treatment Outcome; Vancomycin | 2005 |
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin | 2006 |
Optimizing therapy for MRSA pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcus aureus; Tigecycline; Vancomycin | 2007 |
Nosocomial infections and nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Humans; Pneumonia, Bacterial; Surgical Wound Infection; Urinary Tract Infections; Vancomycin | 1996 |
14 trial(s) available for vancomycin and Pneumonia, Bacterial
| Article | Year |
|---|---|
A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients.
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Female; Hospitalization; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2021 |
Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Female; Humans; Kidney Diseases; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Health Resources; Humans; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Vancomycin | 2019 |
The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Lipoglycopeptides; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Treatment Outcome; Vancomycin | 2014 |
Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a Phase 4 clinical trial study.
Topics: Adult; Aged; Anti-Bacterial Agents; China; Comorbidity; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Female; Health Services; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Models, Econometric; Pneumonia, Bacterial; Renal Insufficiency; Severity of Illness Index; Socioeconomic Factors; Staphylococcal Infections; Vancomycin | 2016 |
A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2016 |
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2008 |
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.
Topics: Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2003 |
Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Thrombocytopenia; Vancomycin | 2003 |
Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial.
Topics: Administration, Oral; Administration, Topical; Aged; Carrier State; Cross Infection; Female; Humans; Intensive Care Units; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2004 |
Pulmonary disposition of vancomycin in critically ill patients.
Topics: Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Critical Illness; Female; Humans; Injections, Intravenous; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial; Staphylococcal Infections; Treatment Outcome; Vancomycin | 1997 |
[Importance of a cefpirome-vancomycin combination on bactericidal kinetics in severe MRSA infections in intensive care].
Topics: Adult; Aged; Bacteremia; Cefpirome; Cephalosporins; Critical Care; Drug Therapy, Combination; Female; Humans; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2002 |
55 other study(ies) available for vancomycin and Pneumonia, Bacterial
| Article | Year |
|---|---|
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Decreasing incidence of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Incidence; Pneumonia, Bacterial; Quinolones; Retrospective Studies; Vancomycin | 2022 |
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in two young children: the importance of an early diagnosis.
Topics: Child, Preschool; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Early Diagnosis; Eosinophilia; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Osteomyelitis; Piperacillin; Pneumonia, Bacterial; Risk Assessment; Sampling Studies; Tobramycin; Vancomycin; Withholding Treatment | 2018 |
Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Hospital Mortality; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Pneumonia, Bacterial; Predictive Value of Tests; Retrospective Studies; Risk Factors; Staphylococcal Infections; Trauma Centers; Vancomycin; Wounds and Injuries | 2013 |
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cross Infection; Humans; Lipoglycopeptides; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2013 |
The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Female; Half-Life; Humans; Hypoalbuminemia; Japan; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Retrospective Studies; Severity of Illness Index; Vancomycin | 2013 |
[Clostridium difficile infection due to ribotype 027: description of an imported case in Spain].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clostridioides difficile; Disease Susceptibility; DNA, Bacterial; DNA, Ribosomal; Enterocolitis, Pseudomembranous; Female; Humans; Intubation, Intratracheal; Pneumonia, Bacterial; Portugal; Ribotyping; RNA, Bacterial; Sequence Deletion; Spain; Vancomycin; Young Adult | 2014 |
Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Acetamides; Administration, Oral; Aged; Anti-Bacterial Agents; Databases, Factual; Electronic Health Records; Female; Humans; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Propensity Score; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Vancomycin; Veterans | 2014 |
Trends of Staphylococcus aureus bloodstream infections in a neonatal intensive care unit from 2000-2009.
Topics: Anti-Bacterial Agents; Birth Weight; Clindamycin; Enterocolitis, Necrotizing; Hospital Mortality; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Retrospective Studies; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Tennessee; Vancomycin | 2014 |
Early acute bioprosthetic valve failure associated with heparin-induced thrombocytopenia.
Topics: Aged; Anti-Bacterial Agents; Anticoagulants; Aortic Valve; Bioprosthesis; Ceftazidime; Coronary Artery Bypass; Drug Therapy, Combination; Fatal Outcome; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Heparin; Humans; Pneumonia, Bacterial; Prosthesis Failure; Thrombocytopenia; Vancomycin | 2014 |
Recurrent linezolid-resistant Enterococcus faecalis infection in a patient with pneumonia.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Pneumonia, Bacterial; Recurrence; Vancomycin; Vancomycin Resistance | 2015 |
Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumonia.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Pneumonia, Bacterial; Practice Guidelines as Topic; Retrospective Studies; United States; United States Department of Veterans Affairs; Vancomycin | 2015 |
Telavancin (Vibativ). A vancomycin derivative, no more effective but more toxic.
Topics: Aminoglycosides; Anti-Bacterial Agents; Humans; Lipoglycopeptides; Pneumonia, Bacterial; Vancomycin | 2015 |
Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Cross Infection; Female; Hospitalization; Humans; Japan; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Bacterial; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Aztreonam; Bacteremia; Ceftazidime; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies; Rifampin; Teicoplanin; Thienamycins; Vancomycin | 2016 |
Community-Acquired Pneumonia in Adults: Diagnosis and Management.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Doxycycline; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Macrolides; Male; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2016 |
Puerperal infection of methicillin-resistant Staphylococcus aureus.
Topics: Adult; Community-Acquired Infections; Female; Follow-Up Studies; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pregnancy; Puerperal Infection; Radiography, Thoracic; Risk Assessment; Severity of Illness Index; Staphylococcal Infections; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2008 |
Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clinical Trials as Topic; Creatinine; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Retrospective Studies; Tissue Distribution; Vancomycin; Young Adult | 2009 |
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2009 |
Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function?
Topics: Anti-Bacterial Agents; Biological Availability; Creatinine; Critical Illness; Humans; Pneumonia, Bacterial; Renal Insufficiency; Vancomycin; Wounds and Injuries | 2010 |
Neonatal community-acquired pneumonia: pathogens and treatment.
Topics: Anti-Bacterial Agents; China; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies; Sputum; Thienamycins; Vancomycin | 2010 |
Susceptibility of Staphylococcus aureus to vancomycin: analysis of minimum inhibitory concentrations in two tertiary care hospitals in eastern South Dakota.
Topics: Anti-Bacterial Agents; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Soft Tissue Infections; South Dakota; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2011 |
On a different level: telavancin versus vancomycin for hospital-acquired pneumonia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2011 |
Diagnosis and management of community-acquired pneumonia in adults.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Influenza Vaccines; Linezolid; Macrolides; Oxazolidinones; Pneumococcal Vaccines; Pneumonia, Bacterial; Practice Guidelines as Topic; Risk Factors; Treatment Outcome; United States; Vancomycin | 2011 |
[Microbial spectrum of nosocomial pneumonia in traumatological patients].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Female; Hospitals; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Wounds and Injuries | 2011 |
Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Toxins; Endocarditis, Bacterial; Exotoxins; Female; Hospital Mortality; Humans; Leukocidins; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Vancomycin | 2011 |
Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Biomarkers; Chi-Square Distribution; Creatinine; Databases as Topic; Female; Humans; Incidence; Intensive Care Units; Kaplan-Meier Estimate; Kidney Diseases; Logistic Models; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; United States; Vancomycin | 2012 |
Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Child, Preschool; Clindamycin; Community-Acquired Infections; Consensus; Drug Substitution; Drug Utilization; Evidence-Based Medicine; Female; Guideline Adherence; Hospitals, Pediatric; Humans; Infant; Inservice Training; Kentucky; Length of Stay; Logistic Models; Male; Patient Readmission; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Practice Patterns, Physicians'; Survival Analysis; Treatment Outcome; Vancomycin | 2012 |
Thoracoscopic treatment of pediatric lung abscess.
Topics: Anti-Bacterial Agents; Bronchial Fistula; Cefotaxime; Chest Tubes; Combined Modality Therapy; Debridement; Drainage; Drug Therapy, Combination; Empyema, Pleural; Equipment Failure; Female; Humans; Infant; Lung Abscess; Male; Necrosis; Pleural Diseases; Pneumonia, Bacterial; Pneumothorax; Postoperative Complications; Radiography; Respiratory Tract Fistula; Therapeutic Irrigation; Thoracoscopy; Vancomycin | 2012 |
Linezolid is superior to vancomycin in experimental pneumonia caused by Superantigen-Producing staphylococcus aureus in HLA class II transgenic mice.
Topics: Acetamides; Animals; Linezolid; Mice; Mice, Inbred BALB C; Mice, Transgenic; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Vancomycin | 2012 |
Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Comorbidity; Empirical Research; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prevalence; Proportional Hazards Models; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2013 |
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine | 2004 |
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Logistic Models; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Survival Analysis; Survival Rate; Vancomycin | 2004 |
Facial submandibular cellulitis associated with late-onset group B streptococcal infection.
Topics: Ampicillin; Cellulitis; Diagnosis, Differential; Drug Therapy, Combination; Face; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Male; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus agalactiae; Vancomycin | 2004 |
Linezolid better than vancomycin in treating drug-resistant pneumonia.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2004 |
Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia.
Topics: Acetamides; Cross Infection; Female; Follow-Up Studies; Humans; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Risk Assessment; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2004 |
Heterogeneous vancomycin-resistant Staphylococcus aureus (hetero-VISA) in Singapore.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Pneumonia, Bacterial; Singapore; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2005 |
Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain.
Topics: Acetamides; Cost Savings; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Health Care Costs; Humans; Linezolid; Male; National Health Programs; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Respiration, Artificial; Retrospective Studies; Spain; Survival Analysis; Treatment Outcome; Vancomycin | 2005 |
Community-acquired MRSA bacteremic necrotizing pneumonia in a patient with scrotal ulceration.
Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Genital Diseases, Male; Humans; Male; Methicillin Resistance; Pneumonia, Bacterial; Risk Factors; Scrotum; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Treatment Outcome; Ulcer; Vancomycin | 2005 |
Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Blood Cell Count; Cyclophosphamide; Disease Models, Animal; Escherichia coli; Female; Immunosuppressive Agents; Leukopenia; Meningoencephalitis; Mice; Mice, Inbred ICR; Models, Animal; Neutropenia; Pneumonia, Bacterial; Random Allocation; Specific Pathogen-Free Organisms; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Vancomycin | 2006 |
[Pneumonia by Corynebacterium pseudodiphteriticum: an infection to consider].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Corynebacterium; Corynebacterium Infections; Diabetes Mellitus, Type 1; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intubation, Intratracheal; Male; Multiple Trauma; Ofloxacin; Pneumonia, Bacterial; Prednisone; Pulmonary Disease, Chronic Obstructive; Sjogren's Syndrome; Smoking; Vancomycin | 2006 |
[Comments on the recommendations for antibiotic treatment of gram positive coccal infections in the critical patient].
Topics: Anti-Bacterial Agents; Critical Illness; Drug Administration Schedule; Health Planning Guidelines; Humans; Methicillin Resistance; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Use of vancomycin for the treatment of Corynebacterium xerosis pneumonia.
Topics: Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Teicoplanin; Vancomycin | 1995 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination; Fluconazole; Fusidic Acid; Humans; Imipenem; Immunocompromised Host; Male; Methicillin Resistance; Nocardia Infections; Pneumonia; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 1996 |
Clinical isolation of vancomycin-resistant Enterococcus faecalis in Taiwan.
Topics: Aged; Bacteremia; Drug Resistance, Microbial; Enterococcus faecalis; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Pneumonia, Bacterial; Polymerase Chain Reaction; Serotyping; Sputum; Vancomycin | 1996 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Diagnostic Errors; Drug Therapy, Combination; Humans; Mycobacterium Infections; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
Susceptibility to vancomycin of methicillin-resistant Staphylococcus aureus isolated in a university hospital in Japan.
Topics: Aged; Drug Resistance, Microbial; Female; Hospitals, University; Humans; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2000 |
Nosocomial pneumonia: importance of recognition of aetiological agents to define an appropriate initial empirical therapy.
Topics: Anti-Bacterial Agents; Bacteria; Blood; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Humans; Lung; Pleural Effusion; Pneumonia, Bacterial; Vancomycin | 2001 |
Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: diagnosis by fine-needle aspiration biopsy.
Topics: Actinomycetales Infections; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antigens, Viral; Antiviral Agents; Azithromycin; Biopsy, Needle; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Immunocompromised Host; Kidney Transplantation; Male; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Viral; Postoperative Complications; Rhodococcus; Tomography, X-Ray Computed; Vancomycin | 2001 |
Minor [correction of Mi1nor] burns and pneumatocoeles: a case report.
Topics: Burns; Child, Preschool; Follow-Up Studies; Humans; Injury Severity Score; Male; Pneumonia, Bacterial; Pneumothorax; Radiography, Thoracic; Risk Assessment; Staphylococcal Infections; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2001 |
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
Topics: Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Drug Incompatibility; Drug Stability; Drug Therapy, Combination; Humans; Infusions, Intravenous; Midazolam; Nicardipine; Pneumonia, Bacterial; Propofol; Temperature; Vancomycin | 2001 |
Pulmonary administration of perfluorodecaline- gentamicin and perfluorodecaline- vancomycin emulsions.
Topics: Animals; Anti-Bacterial Agents; Emulsions; Fluorocarbons; Gentamicins; Infusions, Intravenous; Liquid Ventilation; Pneumonia, Bacterial; Rabbits; Random Allocation; Respiratory Distress Syndrome; Vancomycin | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |